0000899243-23-009000.txt : 20230317
0000899243-23-009000.hdr.sgml : 20230317
20230317203015
ACCESSION NUMBER: 0000899243-23-009000
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230317
DATE AS OF CHANGE: 20230317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boyle Kevin S. Sr.
CENTRAL INDEX KEY: 0001880600
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33038
FILM NUMBER: 23744659
MAIL ADDRESS:
STREET 1: C/O ZIOPHARM ONCOLOGY, INC.
STREET 2: ONE FIRST AVENUE, PARRIS BLDG 34
CITY: BOSTON
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001107421
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841475642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8030 EL RIO STREET
CITY: HOUSTON
STATE: TX
ZIP: 77054
BUSINESS PHONE: (346) 355-4099
MAIL ADDRESS:
STREET 1: 8030 EL RIO STREET
CITY: HOUSTON
STATE: TX
ZIP: 77054
FORMER COMPANY:
FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC
DATE OF NAME CHANGE: 20050919
FORMER COMPANY:
FORMER CONFORMED NAME: EASYWEB INC
DATE OF NAME CHANGE: 20010213
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-15
0
0001107421
Alaunos Therapeutics, Inc.
TCRT
0001880600
Boyle Kevin S. Sr.
C/O ALAUNOS THERAPEUTICS, INC.
8030 EL RIO ST.
HOUSTON
TX
77054
1
1
0
0
Chief Executive Officer
Employee Stock Option (right to buy)
0.50
2023-03-15
4
A
0
1800000
0.00
A
2033-03-14
Common Stock
1800000
1800000
D
One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date.
/s/ Melinda Lackey, Attorney-in-Fact
2023-03-17